Abstract
Introduction: Pressure ulcers, commonly known as bedsores, are localized wounds affecting the skin and underlying tissues. They result from prolonged pressure, friction, or shear. There are different ways to treat pressure ulcers. One way is to give patients extra protein, vitamins like zinc and selenium, and special diets with a lot of eicosapentaenoic acid (EPA). This review looks at how vital nutritional support is in preventing and treating pressure ulcers and how it can be used with new technologies. Combining the findings of studies done between 2019 and 2024, this review finds out what works and still needs to be researched. Results: Special diets have been shown to improve wound healing in certain groups of people significantly. EPA-enriched enteral diets have been shown to reduce ulcer incidence by reducing inflammation and improving blood flow. Conclusions: It is clear that nutritional support plays a crucial but complicated role in treating pressure ulcers. Special diets with EPA or selenium can help with wounds in high-risk groups, but they must be part of a wider care plan that uses cutting-edge technology to get the best results.
Introduction
Decubitus ulcers, or bedsores, represent a significant clinical challenge, with severe cases contributing to mortality rates as high as 60%. Traditionally, prevention strategies have focused on "outside-in" mechanical solutions, such as frequent patient repositioning and specialized mattresses. However, these methods often prove insufficient because they overlook the "inside-out" biological vulnerabilities driven by malnutrition. Poor nutritional status directly impairs collagen synthesis and immune function, rendering the skin more susceptible to breakdown and significantly slowing the healing process. This paper explores the synergy between clinical nutrition and emerging medical technologies to provide a unified approach to ulcer prevention and management.
Methods
The researchers conducted a systematic literature review adhering to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The study synthesized findings from clinical research published between 2019 and 2024.
The search strategy involved screening four major databases: PubMed, Cochrane Library, EMBASE, and Web of Science. From an initial pool of 1,761 records, the authors narrowed the selection to 24 high-quality studies, including Randomized Controlled Trials (RCTs), systematic reviews, and meta-analyses. The review focused on the impact of protein supplementation, arginine, micronutrients (Zinc, Selenium), and Omega-3 fatty acids (EPA/GLA), alongside technological integrations like telemedicine and sensor-embedded cushions.
Key Insights and Bioactive Interventions
The Role of EPA and Omega-3s
Eicosapentaenoic acid (EPA) functions as more than a simple supplement; it acts as a bioactive agent. By reducing pro-inflammatory substances such as prostaglandin E2 and improving microcirculatory blood flow, EPA directly addresses the ischemia that triggers ulcer formation.
Albumin as an Inflammatory Marker
While low serum albumin (<3.0 g/dL) is a known predictor of ulcer risk, it is often a marker of systemic inflammation rather than simple protein deficiency. Effective treatment requires addressing the underlying inflammatory state rather than just increasing protein intake.
Technology-Nutrition Synergy
A pivotal insight is the shift toward "Technology-driven integration." AI systems capable of predicting ulcer risk through movement monitoring can be paired with telemedicine platforms to ensure nutritional adherence, creating a comprehensive, closed-loop care model.
Key Results
The systematic review yielded several significant findings regarding nutritional and mechanical interventions:
- Protein Supplementation: Oral protein intake reduced ulcer incidence by 46% in hip fracture patients compared to standard care.
- Healing Acceleration: The use of selenium-rich probiotics (Lactobacillus brevis LSe) reduced wound healing time by an average of 2.4 days (p = 0.039).
- Specialized Formulas: In neurosurgical patient cohorts, an EPA-enriched diet resulted in zero new ulcers over a 14-day period, whereas the control group developed three.
- Mechanical Relief: AI-driven pressure mapping and innovative mattresses were found to redistribute pressure by up to 32%, significantly lowering the risk of tissue ischemia.
Limitations and Future Directions
Despite the clear benefits of targeted nutritional support, several barriers to universal adoption remain. Specialized formulas (EPA/GLA) and high-tech sensors are often prohibitively expensive, particularly in resource-limited settings. Furthermore, methodological heterogeneity across studies—varying dosages and durations—makes it difficult to establish a universal "gold standard" protocol.
Future research should focus on large-scale, multicenter trials with standardized endpoints. Additionally, cost-effectiveness studies are essential to demonstrate that the high upfront costs of specialized nutrition and AI sensors are offset by the long-term reduction in intensive care expenses and improved patient outcomes.
Summary updated